Xu, L., Zhou, K., Yuan, Y., & Walker, E. V. (2025). Understanding Diagnostic Costs Using Hospital-Based Encounters in the Year Before Diagnosis for Canadian Patients with Malignant Central Nervous System Tumours Compared to Common Cancers. Current Oncology, 32(2), 96.
https://doi.org/10.3390/curroncol32020096
Wu, Y., Walker, E. V., & Yuan, Y. (2024). Regional Variability in Survival for Patients Diagnosed with Selected Central Nervous System Tumours in Canada. Current Oncology, 31(6), 3073-3085.
https://doi.org/10.3390/curroncol31060234
Walker, E. V., Zhou, Y., Wu, Y., Liu, J., Climans, S. A., Davis, F. G., & Yuan, Y. (2023). The incidence and prevalence of primary central nervous system (CNS) tumours in Canada (2010–2017), and the survival of patients diagnosed with CNS tumours (2008–2017). Current Oncology, 30(4), 4311-4328.
https://doi.org/10.3390/curroncol30040329
Walker, E. V., Davis, F. G., Yasmin, F., Smith, T. R., & Yuan, Y. (2023). Incidence and survival of primary central nervous system tumors diagnosed in 4 Canadian provinces from 2010 to 2015. Neuro-Oncology Practice, 10(2), 203-213.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10037937/
Liu, J. L., Walker, E. V., Paudel, Y. R., Davis, F. G., & Yuan, Y. (2022). Brain metastases among cancer patients diagnosed from 2010–2017 in Canada: Incidence proportion at diagnosis and estimated lifetime incidence. Current Oncology, 29(3), 2091-2105.
https://doi.org/10.3390/curroncol29030169
Davis, F. G., Smith, T. R., Gittleman, H. R., Ostrom, Q. T., Kruchko, C., & Barnholtz-Sloan, J. S. (2020). Glioblastoma incidence rate trends in Canada and the United States compared with England, 1995–2015. Neuro-oncology, 22(2), 301-302.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7032629/
Walker, E. V., Ross, J., Yuan, Y., Smith, T. R., & Davis, F. G. (2019). Brain cancer survival in Canada 1996–2008: Effects of sociodemographic characteristics. Current Oncology, 26(3), e292.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588061/
Walker, E. V., Davis, F. G., & CBTR founding affiliates. (2019). Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013. Neuro-oncology, 21(3), 360-369.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380406/pdf/noy195.pdf
Eckstrand, A., Shack, L., Pham, T. M., & Davis, F. (2018). The Impact of Hospital Discharge Linkage on Case Ascertainment of Brain Tumors in the Alberta Cancer Registry, 2010-2015. Journal of registry management, 45(3), 109-116.
http://www.ncra-usa.org/Portals/68/JRM%20Fall%202018%20Final.pdf?ver=2019-03-07-162810-593
Yuan, Y., Amjad, S., Eckstrand, A., Sevick, R., Scott, J., Devji, S., ... & Davis, F. (2018). On Capturing Radiological Diagnoses of Brain Tumors to Provide Complete Population Data in Cancer Registries in Canada. Journal of registry management, 45(4), 167-172.
http://www.ncra-usa.org/Portals/68/JRM%20Winter%202018.pdf?ver=2019-05-10-174139-137
Yuan, Y., Ross, J., Shi, Q., & Davis, F. G. (2017). Conditional survival after a diagnosis of malignant brain tumour in Canada: 2000–2008. Current Oncology, 24(5), e341.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5659157/pdf/conc-24-e341.pdf
Yuan, Y., Shi, Q., Li, M., Nagamuthu, C., Andres, E., & Davis, F. G. (2016). Canadian brain cancer survival rates by tumour type and region: 1992–2008. Canadian Journal of Public Health, 107, e37-e42.
https://doi.org/10.17269/cjph.107.5209
Davis, F., Nagamuthu, C., Ross, J., & Megyesi, J. (2015). Current Status of Brain Tumor Surveillance in Canada and Why it Matters. Journal of Registry Management, 42(4), 139-145.
http://www.ncra-usa.org/Portals/68/PDFs/JRM_Winter.2015_V42.4.pdf?ver=2017-07-27-152259-607
Other Relevant Publications:
Zakaria, D., Shaw, A., Woods, R., De, P., & Davis, F. (2018). Case-Completeness of Nonmalignant Central Nervous System Tumors in the Canadian Cancer Registry, 2011-2015. Journal of registry management, 45(1), 117-131.
http://www.ncra-usa.org/Portals/68/JRM%20Fall%202018%20Final.pdf?ver=2019-03-07-162810-593